DTwP-HB-Hib: Antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old

The new combination of DTwP-HB-Hib vaccines has been developed in Indonesia following World Health Organization (WHO) recommendation and integrated into national immunization program.